Search alternatives:
values decrease » values increased (Expand Search), largest decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
Showing 441 - 460 results of 606 for search '(( ct ((values decrease) OR (larger decrease)) ) OR ( via ((linear decrease) OR (mean decrease)) ))', query time: 0.34s Refine Results
  1. 441

    Supplementary Material for: Case Report of Myeloproliferative Neoplasm Complicated with Hepatic Sinusoidal Obstruction Syndrome and Focal Segmental Glomerulosclerosis by figshare admin karger (2628495)

    Published 2025
    “…Diagnostic investigations included a renal biopsy, which confirmed focal segmental glomerulosclerosis, and an abdominal enhanced CT scan, suggesting hepatic sinusoidal obstruction syndrome. …”
  2. 442

    Image 1_Use of a specialized peptide-based enteral formula containing medium-chain triglycerides for enteral tube feeding in children with cerebral palsy and previous tube feeding... by Aydan Kansu (13015700)

    Published 2025
    “…</p>Results<p>A total of 96 children with CP (mean ± SD age: 5.6 ± 3.2 years, 56.3% were boys) were included. …”
  3. 443

    Ydj1 acetylation impacts multiple aspects of translation. by Siddhi Omkar (12413434)

    Published 2024
    “…Statistical significance was calculated via ANOVA. (*p < 0.05; **p 0.01).</p>…”
  4. 444

    Image 3_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  5. 445

    Table 2_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  6. 446

    Image 2_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  7. 447

    Image 11_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  8. 448

    Image 7_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  9. 449

    Image 8_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  10. 450

    Image 6_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  11. 451

    Image 4_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  12. 452

    Image 9_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  13. 453

    Image 12_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  14. 454

    Image 1_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.jpeg by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  15. 455

    Table 3_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  16. 456

    Image 13_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  17. 457

    Table 1_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  18. 458

    Image 10_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  19. 459

    Image 5_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Vaginal microbiome was characterized via 16S rRNA gene amplicon sequencing. Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). …”
  20. 460

    Figure 5, supplementary figure 7 by Kristen Pleil (11084931)

    Published 2024
    “…</b>a-d) Analysis of single nucleus RNA sequencing of female BNST nuclei (total cells: 38,806; GEO: GSE126836)<sup>78</sup>. a) <i>Crh</i> (CRF) expression (7.7%) in female BNST cells. b) <i>Slc117a6</i> (VGLUT2) expression (7.6%) in female BNST cells. c) <i>Gfap</i> (GFAP) expression (0.7%) in female BNST cells. d) ERα (27%) and ERβ (9%) expression (5% both) in female BNST<sup>GFAP</sup> cells. e-f) Effects of acute bath application of the ERα antagonist methyl-piperidino-pyrazole (MPP) on excitatory synaptic transmission in BNST<sup>CRF</sup> neurons during whole-cell slice electrophysiology recordings in high ovarian E2 female CRF-CrexAi9 reporter mice, as depicted in e. f) Time course of high E2 status BNST<sup>CRF</sup> neurons that displayed an increase, decrease, or variable change in spontaneous excitatory postsynaptic current (sEPSC) frequency (left) and amplitude (right) % change from baseline during the 5-minute MPP wash on application period and 5 minute washout. g-i) Effects of acute bath application of MPP on excitatory synaptic transmission in BNST<sup>CRF</sup> neurons during whole-cell slice electrophysiology recordings in low ovarian E2 female CRF-CrexAi9 reporter mice, as depicted in g. f) Time course of low E2 status BNST<sup>CRF</sup> neurons that displayed an increase, decrease, or variable change in spontaneous excitatory postsynaptic current (sEPSC) frequency (left) and amplitude (right) % change from baseline during the 5-minute MPP wash on application period and 5 minute washout. i) Bath application of MPP (3 μM) had no effect on spontaneous excitatory postsynaptic current (sEPSC) frequency (left) and amplitude (right) in a majority of cells during the 5 min wash on period (Ns = 3 mice, 7 cells). j) Depiction of strategy to site-deliver MPP (10 μM/200 nl/side or saline vehicle (VEH) to the BNST in low E2 females via bilateral indwelling cannulae 10 minutes prior to behavioral testing. k) ERα antagonism via intra-BNST MPP did not alter binge EtOH drinking in low ovarian E2 status females (Ns = 8 VEH, 8 MPP). l) BNST cannula hit map (for Fig. 4d-e, 5j-l); each dot is an individual hit. …”